Hopkins researchers to lead independent study of 'next generation' ethics issues

A pioneering Johns Hopkins stem cell expert and one of the institution's leading bioethicists have won a multi-year grant from the Greenwall Foundation to develop far-reaching recommendations on a "second generation" of ethical questions about stem cell research.

John D. Gearhart, Ph.D., and bioethicist Ruth Faden, Ph.D., M.P.H., say the "Ethics and Cell Engineering: The Next Generation" project builds on their long-standing, informal partnership dedicated to carefully navigating the frontiers of human developmental biology.

"We want to take these issues to a relatively mature level of analysis before they become political footballs, so as to provide the public, policy makers and the scientific community with a reasoned backdrop for the decisions they will inevitably face," says Faden, the Philip Franklin Wagley Professor of Biomedical Ethics at Hopkins and executive director of the Phoebe R. Berman Bioethics Institute of The Johns Hopkins University.

In the first 18 months of the project, invited experts in genetics, transplantation, ethics, stem cell science and law will meet to share their views on the need for and possible nature of criteria for selecting stem cell lines from which medical therapies would ultimately be developed. Issues include questions of safety, transplant rejection, privacy, genetic diversity and public access, says Faden.

"The dilemma in this case boils down to what might be needed to ensure sufficient, safe stem cells for future potential therapies from which all of us can benefit," adds Gearhart, whose lab discovered human embryonic germ cells, a type of all-purpose stem cell derived from fetal tissue. "For example, right now we don't know if the immune profile of the cells would need to match the recipient if used as a medical therapy, but it's possible and even likely, and that would probably require more cell lines than we have now."

The project represents the first activity of the Bioethics

Contact: Joanna Downer
Johns Hopkins Medical Institutions

Page: 1 2

Related biology news :

1. Hopkins scientists use blood proteins to detect ovarian cancer
2. Hopkins to found first center for comprehensive study of epigenetics
3. Hopkins scientists overcome main obstacle to making tons of short, drug-like proteins
4. Hopkins Marine Station honored by the American Society for Microbiology
5. Johns Hopkins gene hunters pinpoint new cancer gene target
6. Hopkins researchers identify transplantation antigens among Sioux Indians
7. Hopkins researchers discover how nitric oxide prevents blood vessel inflammation
8. Hopkins is first US institution to obtain powerful genotyping system
9. Dr. Robot tested at Hopkins
10. From Hopkins: Children may outgrow peanut allergies
11. OXiGENE announces launch of ophthalmic clinical trial at The Johns Hopkins School of Medicine

Post Your Comments:

(Date:4/30/2020)... N.M. (PRWEB) , ... April 28, 2020 , ... ... the world’s biggest challenges in agriculture and aquaculture with the mission of improving global ... at the 2020 F&A Next ' Next Heroes in Food- and Ag-Tech ' virtual ...
(Date:4/26/2020)... ... April 23, 2020 , ... ... miniaturization, backed by FII Tech Growth managed by Fondo Italiano d’Investimento SGR, today ... market, for the development of Respira, a new non-invasive pulmonary ventilator created in ...
(Date:4/22/2020)... (PRWEB) , ... April 21, 2020 , ... ... Ideaship, a patent leveraged venture capital firm that provides patent development support for ... to detect and treat illnesses such as ovarian cancer and precancerous pancreatic lesions ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... May 14, 2020 , ... This new service offers clients a way to ... answered quickly as the need arises. Lachman’s OnCall SMEs have extensive knowledge of a ... , Lachman OnCall™ SMEs are available normal business hours Monday through Friday from ...
(Date:5/14/2020)... , ... May 13, 2020 , ... ... assays or phenotypic readouts, providing little or no information on the drug’s mechanism ... more comprehensive characterization of compounds by measuring the activity of molecular pathways. This ...
(Date:5/1/2020)... ... April 30, 2020 , ... The ... the businesses, policies, projects, and concepts that are actively engaged and deeply committed ... cells, which has taken out the top prize in the Experimental category. , ...
(Date:4/22/2020)... ARBOR, Mich. (PRWEB) , ... April 21, 2020 ... ... clinical researchers continue their work through COVID-19. Many clinical trial teams are working ... work online. Ripple Science wants to help researchers continue their research during this ...
Breaking Biology Technology:
Cached News: